Long non-coding RNA regulation of TRAIL in breast cancer: A tangle of non-coding threads

Zeeshan Javed1, Khushbukhat Khan2, Muhammad Zaheer Iqbal3

  • 1Office for Research Innovation and Commercialization, Lahore Garrison University, Lahore, Punjab 54792, Pakistan.

Oncology Letters
|August 18, 2020
PubMed

Insights

Long non-coding RNAs (lncRNAs) regulate breast cancer progression and drug resistance. This review explores lncRNA interplay with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) signaling, offering new therapeutic strategies for breast cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Breast cancer presents a significant global health challenge due to its complex molecular characteristics and heterogeneity.
  • Tumor heterogeneity contributes to drug resistance, metastasis, and invasiveness in breast cancer.
  • Despite advancements, effective breast cancer cures remain elusive, highlighting the need for novel therapeutic targets.

Purpose of the Study:

  • To elucidate the role of long non-coding RNAs (lncRNAs) in regulating breast cancer.
  • To investigate the interplay between lncRNAs and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) signaling in breast cancer.
  • To explore the potential of lncRNA-TRAIL interactions as a basis for new breast cancer diagnostics and therapeutics.

Main Methods:

  • Literature review focusing on lncRNAs in breast cancer.
  • Analysis of existing studies on apoptosis regulation in breast cancer.
  • Examination of the mechanisms underlying TRAIL signaling pathway in breast cancer.

Main Results:

  • lncRNAs are implicated in breast cancer development, proliferation, and metastasis.
  • Dysregulation of apoptosis is a key factor in breast cancer progression and treatment resistance.
  • lncRNAs modulate the apoptosis-regulating machinery, including the TRAIL signaling pathway.

Conclusions:

  • lncRNAs play a critical role in breast cancer pathogenesis and progression.
  • The interaction between lncRNAs and TRAIL signaling represents a promising avenue for therapeutic intervention.
  • Targeting lncRNA-mediated apoptosis regulation could lead to novel diagnostic and therapeutic strategies for breast cancer.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.2K